Evidence map›Paper›PMID 40445471›Full record

ReviewClinical pharmacokinetics2025

Clinical Pharmacology of Loop Diuretics in Critical Care.

Fiorenza Ferrari, Christian Zanza, Manfredi Tesauro, Yaroslava Longhitano, Raymond Planinsic, Antonio Voza, Jacopo Fumagalli, Vittorio Scaravilli, Giacomo Grasselli

Abstract readReview
In one paragraph

Review in Clinical pharmacokinetics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Fiorenza FerrariInternational Renal Research Institute of Vicenza (IRRIV), Department of Nephrology, Dialysis and Transplantation, San Bortolo Hospital, Azienda ULSS 8 Berica, Vicenza, Italy.
Christian ZanzaGeriatric Medicine Residency Program, University of Rome "Tor Vergata", Rome, Italy. christian.zanza@live.it.ORCID 0000-0001-5764-6118
Manfredi TesauroGeriatric Medicine Residency Program, University of Rome "Tor Vergata", Rome, Italy.
Yaroslava LonghitanoDepartment of Anaesthesiology and Perioperative Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Raymond PlaninsicDepartment of Anaesthesiology and Perioperative Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Antonio VozaDepartment of Emergency Medicine-Emergency Medicine Residency Program, Humanitas University-Research Hospital, Rozzano, Italy.
Jacopo FumagalliDepartment of Anaesthesia, Critical Care and Emergency, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Vittorio ScaravilliDepartment of Biomedical, Surgical and Dental Sciences, University of Milan, Milan, Italy.
Giacomo GrasselliDepartment of Pathophysiology and Transplantation, University of Milan, Milan, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Loop diuretics are a cornerstone in the management of fluid overload in critically ill patients; however, their use is often complicated by variable pharmacokinetics and the phenomenon of diuretic resistance. This narrative review comprehensively examines the pharmacokinetic properties of loop diuretics and discusses the implications of altered pharmacokinetics due to factors such as organ dysfunction, fluid shifts, and concomitant medications, highlighting the challenges in achieving therapeutic targets. Furthermore, we explore the adverse events associated with loop diuretic administration, including electrolyte imbalances and ototoxicity. The review delves into the concept of diuretic resistance, exploring its multifactorial origins, including altered pharmacodynamics and increased compensatory mechanisms. Various strategies to overcome diuretic resistance are presented, including combination therapy with other diuretics, optimizing dosing regimens, and utilizing novel pharmacological agents. Given the complexity of loop diuretic therapy in critically ill patients, a tailored approach is crucial for optimizing fluid management and mitigating adverse effects. This review aims to inform clinicians about the nuances of loop diuretic use in critical care settings, providing insights into pharmacological strategies and clinical considerations essential for enhancing patient outcomes.

Indexed as

Critical CareSodium Potassium Chloride Symporter InhibitorsCritical IllnessDiureticsHumansDiureticsSodium Potassium Chloride Symporter Inhibitors

Identifiers

PMID40445471
PMCPMC12185637

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.